SERI INDUSTRIAL SPA (SERI.MI) Stock Fundamental Analysis
BIT:SERI - Euronext Milan - IT0005283640 - Common Stock - Currency: EUR
Overall SERI gets a fundamental rating of 4 out of 10. We evaluated SERI against 67 industry peers in the Chemicals industry. There are concerns on the financial health of SERI while its profitability can be described as average. SERI is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year SERI was profitable.
SERI had a positive operating cash flow in the past year.
In the past 5 years SERI reported 4 times negative net income.
Of the past 5 years SERI 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 3.30%, SERI is in the better half of the industry, outperforming 64.18% of the companies in the same industry.
SERI has a better Return On Equity (16.27%) than 88.06% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.28%, SERI is in line with its industry, outperforming 40.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.3% | ||
| ROE | 16.27% | ||
| ROIC | 0.28% |
ROA(3y)-0.2%
ROA(5y)-0.47%
ROE(3y)1.35%
ROE(5y)-0.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SERI's Profit Margin of 12.46% is amongst the best of the industry. SERI outperforms 91.04% of its industry peers.
SERI's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 0.85%, SERI perfoms like the industry average, outperforming 40.30% of the companies in the same industry.
In the last couple of years the Operating Margin of SERI has declined.
SERI's Gross Margin of 45.65% is fine compared to the rest of the industry. SERI outperforms 65.67% of its industry peers.
SERI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.85% | ||
| PM (TTM) | 12.46% | ||
| GM | 45.65% |
OM growth 3YN/A
OM growth 5Y-22.17%
PM growth 3YN/A
PM growth 5Y63.23%
GM growth 3Y-0.52%
GM growth 5Y-1.68%
2. Health
2.1 Basic Checks
SERI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SERI remains at a similar level compared to 1 year ago.
Compared to 5 years ago, SERI has more shares outstanding
Compared to 1 year ago, SERI has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.50, we must say that SERI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SERI (0.50) is worse than 82.09% of its industry peers.
SERI has a Debt/Equity ratio of 0.81. This is a neutral value indicating SERI is somewhat dependend on debt financing.
SERI has a worse Debt to Equity ratio (0.81) than 71.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.5 |
ROIC/WACC0.04
WACC7.72%
2.3 Liquidity
A Current Ratio of 1.13 indicates that SERI should not have too much problems paying its short term obligations.
SERI has a worse Current ratio (1.13) than 82.09% of its industry peers.
SERI has a Quick Ratio of 1.13. This is a bad value and indicates that SERI is not financially healthy enough and could expect problems in meeting its short term obligations.
SERI's Quick ratio of 0.75 is on the low side compared to the rest of the industry. SERI is outperformed by 82.09% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.75 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 332.80% over the past year.
Measured over the past years, SERI shows a very strong growth in Earnings Per Share. The EPS has been growing by 72.87% on average per year.
SERI shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.16%.
Measured over the past years, SERI shows a small growth in Revenue. The Revenue has been growing by 7.08% on average per year.
EPS 1Y (TTM)332.8%
EPS 3YN/A
EPS 5Y72.87%
EPS Q2Q%1019.75%
Revenue 1Y (TTM)21.16%
Revenue growth 3Y8.52%
Revenue growth 5Y7.08%
Sales Q2Q%53.4%
3.2 Future
The Earnings Per Share is expected to grow by 35.33% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 33.28% on average over the next years. This is a very strong growth
EPS Next Y31.15%
EPS Next 2Y35.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year52.97%
Revenue Next 2Y33.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
SERI is valuated cheaply with a Price/Earnings ratio of 4.55.
100.00% of the companies in the same industry are more expensive than SERI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.92, SERI is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for SERI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.55 | ||
| Fwd PE | N/A |
4.2 Price Multiples
SERI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SERI is cheaper than 80.60% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 6.21 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SERI's earnings are expected to grow with 35.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)0.06
EPS Next 2Y35.33%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for SERI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:SERI (6/27/2025, 4:02:29 PM)
2.185
-0.02 (-0.68%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners5.35%
Inst Owner ChangeN/A
Ins Owners56.47%
Ins Owner ChangeN/A
Market Cap117.95M
Analysts80
Price Target5.41 (147.6%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.55 | ||
| Fwd PE | N/A | ||
| P/S | 0.59 | ||
| P/FCF | N/A | ||
| P/OCF | 5.86 | ||
| P/B | 0.76 | ||
| P/tB | 2.8 | ||
| EV/EBITDA | 6.21 |
EPS(TTM)0.48
EY21.97%
EPS(NY)-0.25
Fwd EYN/A
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)0.37
OCFY17.07%
SpS3.73
BVpS2.86
TBVpS0.78
PEG (NY)0.15
PEG (5Y)0.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.3% | ||
| ROE | 16.27% | ||
| ROCE | 0.4% | ||
| ROIC | 0.28% | ||
| ROICexc | 0.31% | ||
| ROICexgc | 0.43% | ||
| OM | 0.85% | ||
| PM (TTM) | 12.46% | ||
| GM | 45.65% | ||
| FCFM | N/A |
ROA(3y)-0.2%
ROA(5y)-0.47%
ROE(3y)1.35%
ROE(5y)-0.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-28.62%
ROICexc growth 3YN/A
ROICexc growth 5Y-27.84%
OM growth 3YN/A
OM growth 5Y-22.17%
PM growth 3YN/A
PM growth 5Y63.23%
GM growth 3Y-0.52%
GM growth 5Y-1.68%
F-Score4
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.55 | ||
| Cap/Depr | 262.02% | ||
| Cap/Sales | 43.43% | ||
| Interest Coverage | 0.15 | ||
| Cash Conversion | 57.32% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.75 | ||
| Altman-Z | 0.5 |
F-Score4
WACC7.72%
ROIC/WACC0.04
Cap/Depr(3y)145.33%
Cap/Depr(5y)149.98%
Cap/Sales(3y)22.86%
Cap/Sales(5y)20.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)332.8%
EPS 3YN/A
EPS 5Y72.87%
EPS Q2Q%1019.75%
EPS Next Y31.15%
EPS Next 2Y35.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.16%
Revenue growth 3Y8.52%
Revenue growth 5Y7.08%
Sales Q2Q%53.4%
Revenue Next Year52.97%
Revenue Next 2Y33.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y118.77%
EBIT growth 3YN/A
EBIT growth 5Y-16.66%
EBIT Next Year172.82%
EBIT Next 3Y71.55%
EBIT Next 5Y36.46%
FCF growth 1Y-229.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-73.66%
OCF growth 3Y18.22%
OCF growth 5Y-8.47%